Fingolimod granted FDA Breakthrough Therapy designation for paediatric MS
Novartis today announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for fingolimod for the treatment of children and adolescents 10 years of age or older with relapsing multiple sclerosis (MS)...Read more - http://www.ms-uk.org/fingolimod-granted ... diatric-ms
Fingolimod granted FDA Breakthrough Therapy designation...
Fingolimod granted FDA Breakthrough Therapy designation...
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 2276 Views
-
Last post by frodo
-
- 0 Replies
- 10583 Views
-
Last post by NHE
-
- 2 Replies
- 1659 Views
-
Last post by jimmylegs
-
- 0 Replies
- 1871 Views
-
Last post by Petr75
-
- 0 Replies
- 1248 Views
-
Last post by NHE
-
- 2 Replies
- 1909 Views
-
Last post by frodo
-
- 0 Replies
- 11282 Views
-
Last post by NHE
-
- 0 Replies
- 2607 Views
-
Last post by frodo
-
- 0 Replies
- 2753 Views
-
Last post by NHE